We are live on ! Find out more
TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

18 hedge funds and large institutions have $179K invested in Titan Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

6% more funds holding

Funds holding: 17 → 18 (+1)

0.75% less ownership

Funds ownership: 4.28% → 3.54% (-0.75%)

22% less capital invested

Capital invested by funds: $230K → $179K (-$50.7K)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$475
2
Bank of America
Bank of America
North Carolina
+$34
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$7

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$27
Name Holding Trade Value Shares
Change 		Change in
Stake
Truist Financial
1
Truist Financial
North Carolina
$174K – – –
TRCT
2
Tower Research Capital (TRC)
New York
$3.99K +$475 +70 +11%
MA
3
MCF Advisors
Kentucky
$920 – – –
Bank of America
4
Bank of America
North Carolina
$95 +$34 +5 +42%
Group One Trading
5
Group One Trading
Illinois
$66 – – –
Osaic Holdings
6
Osaic Holdings
Arizona
$54 – – –
Morgan Stanley
7
Morgan Stanley
New York
$17 – – –
GWSA
8
Global Wealth Strategies & Associates
Colorado
$11 – – –
Wells Fargo
9
Wells Fargo
California
$6 -$27 -4 -80%
CSC
10
Caldwell Sutter Capital
California
$6 – – –
CIA
11
Cape Investment Advisory
Georgia
$6 – – –
DJSG
12
D.J. St. Germain
Massachusetts
$6 – – –
NRG
13
Nemes Rush Group
Michigan
$6 – – –
NA
14
NewEdge Advisors
Louisiana
$6 – – –
RA
15
Ransom Advisory
Rhode Island
$6 – – –
UBS Group
16
UBS Group
Switzerland
$6 – – –
WIM
17
Westside Investment Management
California
$6 – – –
Fidelity Investments
18
Fidelity Investments
Massachusetts
$5 +$7 +1 New

TTNP Hedge Fund Activity: Q2 2024 in Review

18 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q2 2024, worth a combined $179K — down 22% from $230K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new TTNP positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $475. The largest seller was Wells Fargo, cutting an estimated $27.

  • 18 institutional investors held Titan Pharmaceuticals (TTNP) as of Q2 2024, up from 17 in Q1 2024.
  • Funds reported $179K of Titan Pharmaceuticals stock for Q2 2024, down 22% quarter-over-quarter.
  • 1 fund opened new Titan Pharmaceuticals positions in Q2 2024 and 0 closed out, a net change of +1 holder.
  • The largest Titan Pharmaceuticals buyer in Q2 2024 was Tower Research Capital (TRC), an estimated $475 added.
  • The largest Titan Pharmaceuticals seller in Q2 2024 was Wells Fargo, an estimated $27 sold.

Based on aggregated 13F filings for Q2 2024.